PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
批准号:
6173152
负责人:
PETER C. BROOKS
金额:
$4.71万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-05 至 2000-08-31
中文摘要
描述:(改编自研究者摘要)主要目的
该提案的目的是定义胶原蛋白降解的特定作用,
血管生成过程中的组织重塑。 调查员建议检查
间质蛋白水解修饰的功能意义
I型胶原是血管细胞外基质的主要成分,
在历史上被认为是调节组织的结构成分
形态发生和稳定性。 血管生成被认为依赖于
细胞粘附和蛋白水解机制。 然而,迄今为止,
已知细胞粘附受体和蛋白水解降解
细胞外基质(ECM)成分在细胞内协同作用,
调节体内血管生成。 潜在的细胞和生化
蛋白水解降解胶原蛋白的机制,
片段可以作为血管整联蛋白α V β 3的配体,
将检测增强内皮细胞存活和血管生成。
假设是基质金属蛋白酶(MMPs),主要的一类
能够特异性降解间质胶原蛋白的酶,
调节并选择性地与体内血管生成血管相关。
将确定升高水平的MMP是否在肿瘤细胞中表达。
蛋白水解活性形式,可以启动蛋白水解的
血管生成血液直接微环境中的间质胶原
船舶. 胶原蛋白的蛋白水解降解揭示
提供生理上重要的配体的隐蔽的粘附序列
对于连接所必需的血管整合素α v β 3介导的事件
内皮细胞存活和血管生成的影响。 以来
血管生成在各种正常和病理性的
过程,了解调节这一过程的分子事件是
这不仅对我们基本的理解,
血管生成,而且设计新的治疗策略,
以新生血管形成为特征的疾病 因此本研究
应该提供新的信息,以弥合我们在理解上的差距。
调节体内新血管形成的复杂机制,
提供了第一个证据,证明蛋白水解胶原蛋白在
内皮细胞存活和血管生成的调节。
英文摘要
DESCRIPTION: (adapted from the investigator's abstract) The major objective
of this proposal is to define a specific role for collagen degradation and
tissue remodeling during angiogenesis. The investigator proposes to examine
the functional significance of proteolytic modification of interstitial
collagen type-I, a major component of the vascular extracellular matrix that
has historically been considered as a structural component regulating tissue
morphogenesis and stability. Angiogenesis has been suggested to depend on
both cell adhesion and proteolytic mechanisms. However, to date, little is
known concerning how cell adhesion receptors and proteolytically degraded
extracellular matrix (ECM) components function cooperatively in the
regulation of angiogenesis in vivo. The potential cellular and biochemical
mechanisms by which proteolytically degraded collagen and resulting
fragments can function as a ligand for vascular integrin alphav beta3,
potentiating endothelial cell survival and angiogenesis will be examined.
The hypothesis is that matrix metalloproteinases (MMPs), the primary class
of enzymes capable of specifically degrading interstitial collagen, are up
regulated and selectively associated with angiogenic blood vessels in vivo.
It will be determined whether the elevated levels of MMPs are expressed in a
proteolytically active form that could initiate the formation of proteolyzed
interstitial collagen in the immediate microenvironment of angiogenic blood
vessels. The ability of proteolytic degradation of collagen to reveal
cryptic adhesive sequences that provide a physiologically important ligand
for vascular integrin alphav beta3-mediated event necessary for the ligation
of endothelial cell survival and angiogenesis will be tested. Since
angio-genesis plays a critical role in a variety of normal and pathological
processes, understanding the molecular events that regulate this process is
of paramount importance, not only to our basic understanding of
angiogenesis, but also to the design of novel strategies for the treatment
of diseases characterized by neovascularization. Therefore, this study
should provide new information to bridge the gap in our understanding of the
complex mechanisms that regulate new blood vessels formation in vivo and
provide the first evidence for a specific role for proteolyzed collagen in
the regulation of endothelial cell survival and angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth
-
批准号:10056977
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2016
-
负责人:PETER C. BROOKS
-
依托单位:
ROLE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) IN ANGIOGENESIS
-
批准号:7959661
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2009
-
负责人:PETER C. BROOKS
-
依托单位:
ROLE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) IN ANGIOGENESIS
-
批准号:7720101
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2008
-
负责人:PETER C. BROOKS
-
依托单位:
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH
-
批准号:6790509
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
Cryptic Domains of Collagen-IV in Tumor Growth
-
批准号:7825335
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
Cryptic Domains of Collagen-IV in Tumor Growth
-
批准号:8069854
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH
-
批准号:6344203
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
Cryptic Domains of Collagen-IV in Tumor Growth
-
批准号:7624694
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH
-
批准号:6522686
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
Cryptic Domains of Collagen-IV in Tumor Growth
-
批准号:7314048
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH
-
批准号:6642724
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
Cryptic Domains of Collagen-IV in Tumor Growth
-
批准号:7485790
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH
-
批准号:7280676
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
CRYPTIC DOMAINS OF COLLAGEN IV IN TUMOR GROWTH
-
批准号:6378228
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2000
-
负责人:PETER C. BROOKS
-
依托单位:
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
-
批准号:2683708
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1997
-
负责人:PETER C. BROOKS
-
依托单位:
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
-
批准号:2895928
-
项目类别:
-
资助金额:$11.45万
-
财政年份:1997
-
负责人:PETER C. BROOKS
-
依托单位:
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
-
批准号:2642924
-
项目类别:
-
资助金额:$8.01万
-
财政年份:1997
-
负责人:PETER C. BROOKS
-
依托单位:
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
-
批准号:6440463
-
项目类别:
-
资助金额:$11.55万
-
财政年份:1997
-
负责人:PETER C. BROOKS
-
依托单位:
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
-
批准号:6350228
-
项目类别:
-
资助金额:$6.74万
-
财政年份:1997
-
负责人:PETER C. BROOKS
-
依托单位:
PROTEOLYZED COLLAGEN IN ANGIOGENESIS AND APOPTOSIS
-
批准号:2012124
-
项目类别:
-
资助金额:$3.75万
-
财政年份:1997
-
负责人:PETER C. BROOKS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: